NCT03145428

Brief Summary

The measurement of monocyte volume width distribution (MDW) is intended for use with adult patients presenting to the emergency department (ED), where a CBC with Differential has been ordered, as an aid in the early detection of patients with or developing sepsis. The study will establish the clinical performance of MDW for detection of sepsis in the ED.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
3,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jun 2017

Shorter than P25 for all trials

Geographic Reach
1 country

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 4, 2017

Completed
5 days until next milestone

First Posted

Study publicly available on registry

May 9, 2017

Completed
1 month until next milestone

Study Start

First participant enrolled

June 19, 2017

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 22, 2017

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

January 26, 2018

Completed
Last Updated

November 22, 2019

Status Verified

November 1, 2019

Enrollment Period

6 months

First QC Date

May 4, 2017

Last Update Submit

November 21, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • Identification of sepsis vs. non-sepsis, including SIRS and infection (non-SIRS) by adjudication based on the 2001 SCCM sepsis definition (sepsis-2)

    Determination of the diagnostic accuracy, area under the receiver operating characteristic curve

    12 hours after presentation to the ED

Interventions

MDW measurement used to detect sepsis. Results will not be used to manage patients

Eligibility Criteria

Age18 Years - 89 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

All adult patients with suspicion who present to ED and for whom CBC with Diff is performed upon ED presentation.

You may qualify if:

  • Adults (18-89 years) presenting to ED
  • All races \& ethnicities
  • CBC with Differential performed upon presentation
  • Subjects with at least 12 hours of follow-up in ED (or in-patient if admitted)

You may not qualify if:

  • Previously enrolled
  • Subjects discharged \<12 hours form ED presentation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Hackensack University Medical Center

Hackensack, New Jersey, 07601, United States

Location

The Ohio State University

Columbus, Ohio, 43210, United States

Location

University of Pittsburgh Medical Center

Pittsburgh, Pennsylvania, 15213, United States

Location

Related Publications (1)

  • Crouser ED, Parrillo JE, Martin GS, Huang DT, Hausfater P, Grigorov I, Careaga D, Osborn T, Hasan M, Tejidor L. Monocyte distribution width enhances early sepsis detection in the emergency department beyond SIRS and qSOFA. J Intensive Care. 2020 May 5;8:33. doi: 10.1186/s40560-020-00446-3. eCollection 2020.

MeSH Terms

Conditions

SepsisInfections

Condition Hierarchy (Ancestors)

Systemic Inflammatory Response SyndromeInflammationPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 4, 2017

First Posted

May 9, 2017

Study Start

June 19, 2017

Primary Completion

December 22, 2017

Study Completion

January 26, 2018

Last Updated

November 22, 2019

Record last verified: 2019-11

Locations